Riskpilot← Back to searchSign inGet full accessHälsokonsulterna i Uppsala AB
ABActiveOrg 5592070089Västra Järnvägsgatan 23 BGeneral medical practice activities · NACE 8621Est. 20190 employees
Revenue 2024
SEK 601K
+192% vs 2023
EBITDA margin
-1.3%
-144% vs 2023
Equity ratio
53.4%
Financial strength
Net profit 2024
SEK -7K
-150% vs 2023
| Revenue | SEK 601K | +192% |
| EBITDA | SEK -8K | -144% |
| Net profit | SEK -7K | -150% |
| Total assets | SEK 163K | -17% |
| Equity | SEK 87K | -8% |
| Employees | 0 | — |
Legal name
Hälsokonsulterna i Uppsala AB
Org number
5592070089
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
24 maj 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget skall genomföra teambaserade arbetsförmågeutredningar. Hälso och sjukvård, utredning och rehabilitering.
Address
Västra Järnvägsgatan 23 B
Email
info@rehabresurs.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 135 | 1 062 | 469 | 206 | 601 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 43 | 297 | 14 | 18 | −8 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 43 | 297 | 14 | 18 | −8 |
| Net financials | — | — | — | — | — |
| Profit before tax | 43 | 297 | 14 | 18 | −7 |
| Tax | −9 | −62 | −3 | −4 | −0 |
| Net profit | 34 | 235 | 11 | 14 | −7 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 193 | 595 | 461 | 196 | 163 |
| Equity | 84 | 319 | 330 | 95 | 87 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 109 | 276 | 131 | 101 | 75 |
| Total debt | 109 | 276 | 131 | 101 | 75 |
EBITDA margin
-1.3%
This company
15.8%
Market median
-108% vs market
20202024
Equity ratio
53.4%
This company
38.2%
Market median
+40% vs market
20202024
Return on equity
-8.0%
This company
18.4%
Market median
-143% vs market
20202024
Net profit margin
-1.2%
This company
8.1%
Market median
-115% vs market
20202024
Asset turnover
3.69×
This company
1.12×
Market median
+229% vs market
20202024
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AM Chief Executive Officer | Chief Executive Officer | 2022 |
AC Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hälsokonsulterna i Uppsala AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Maria Helena Petersson | Chief Executive Officer | 0 companies |
| Anders Christer Fernkvist | Deputy Chief Executive Officer | 0 companies |
| Linda Anna Lindquist | Chairman | 0 companies |